Publications by authors named "Loic Trapani"
Purpose: Steatohepatitic hepatocellular carcinoma (SH-HCC) is characterized by intratumoral fat with > 50% inflammatory changes. However, intratumoral fat (with or without inflammation) can also be found in not-otherwise specified HCC (NOS-HCC). We compared the imaging features and outcome of resected HCC containing fat on pathology including SH-HCC (> 50% steatohepatitic component), NOS-HCC with < 50% steatohepatitic component (SH-NOS-HCC), and fatty NOS-HCC (no steatohepatitic component).
View Article and Find Full Text PDFAims: According to the last WHO classification, steatohepatitic hepatocellular carcinoma (SH-HCC) is recognized as a distinct HCC subtype, even though a consensual definition is still lacking. The objectives of the study were to carefully describe the morphological features of SH-HCC and evaluate its impact on prognosis.
Methods And Results: We conducted a single-centre retrospective study including 297 surgically resected HCC.
Article Synopsis
- The study investigates how different subtypes of hepatocellular carcinoma (HCC) influence LI-RADS imaging features and classifications in patients who underwent tumor resection.
- It involves a review of imaging data from 277 patients with various HCC subtypes, where common imaging characteristics were assessed by three radiologists.
- Findings indicate that while some features are more prevalent in specific subtypes, the overall distribution of LI-RADS categories remains similar across these HCC types in high-risk patients.*
Purpose: The purpose of this study was to compare the value of contrast-enhanced computed tomography (CT) to that of magnetic resonance imaging obtained with extracellular contrast agent (ECA-MRI) for the diagnosis of a tumor capsule in hepatocellular carcinoma (HCC) using histopathologic findings as the standard of reference.
Materials And Methods: This retrospective study included patients with pathologically-proven resected HCCs with available preoperative contrast-enhanced CT and ECA-MRI examinations. Two blinded radiologists independently reviewed contrast-enhanced CT and ECA-MRI examinations to assess the presence of an enhancing capsule.